ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
-0.05%
S&P ASX All Technology
3,074.90
-0.10%
Brent Oil
81.665
-0.95%
US Dollar vs AUD
1.50338
0.23%
Bitcoin
69,544.41
-0.84%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seagen Inc (SGEN)

  7. Seagen Inc (SGEN) News

SGEN

Seagen (SGEN)

Seagen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SGEN
DateTimeSourceHeadlineSymbolCompany
09/01/202422:12IH Market NewsWall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and MoreNASDAQ:SGENSeagen Inc
26/12/202322:12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SGENSeagen Inc
19/12/202310:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
19/12/202309:25Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SGENSeagen Inc
16/12/202310:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202310:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGENSeagen Inc
16/12/202309:00PR Newswire (US)PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder CancerNASDAQ:SGENSeagen Inc
15/12/202300:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:43Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:42Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:41Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
15/12/202300:37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGENSeagen Inc
 Showing the most relevant articles for your search:NASDAQ:SGEN

Your Recent History

ASX
XMM
S&P ASX 300 Metals and M...
FX
AUDUSD
AUD vs US Dollar
NYSE
MRK
Merck
NASDAQ
AAPL
Apple
ASX
WOW
Woolworths
ASX
WPL
Woodside Petroleum
ASX
FMG
Fortescue
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
ASX
XAO
Australian SE All Ordina...
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
ASX
NCM
Newcrest Mining
ASX
CSL
CSL
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved